Zusammenfassung
Klinisches/methodisches Problem
Der kontrastmittelverstärkte Ultraschall (CEUS) gewinnt zunehmend an Bedeutung für die Erkennung und Charakterisierung maligner Leberläsionen und ermöglicht durch die Bildgebung eine perkutane Behandlung, wenn eine Operation nicht möglich ist. Die zusätzliche Kombination der Bildfusion mit Computertomographie (CT) und Magnetresonanztomographie (MRT) eröffnet weitere Möglichkeiten zur gezielten Untersuchung oder einer modifizierten Tumorbehandlung.
Methodische Innovationen
Die Fusionsbildgebung bietet die Möglichkeit der Echtzeit-Bildgebung und kann mit anderen schnittbildgebenden Verfahren sowie mit CEUS kombiniert werden.
Leistungsfähigkeit
Die Sonographie hat mit der Einführung von Ultraschallkontrastmitteln und der Bildfusion sowohl beim Nachweis als auch bei der Charakterisierung von Leberläsionen zu den anderen Schnittbildverfahren aufgeschlossen. Zusätzlich kann dieses Verfahren auch zur Intervention genutzt werden. Die Erfolgsrate von fusionsgesteuerten Punktionen oder CEUS-unterstützten Tumorablationen liegt je nach Literatur zwischen 80–100 %.
Bewertung
Die sonographisch gestützte Bildfusion mittels CT oder MRT kann, in Kombination mit CEUS, die Diagnostik und Therapiekontrolle nach Interventionen der Leber erleichtern.
Empfehlung für die Praxis
Neben den primären Anwendungen der Bildfusion im Rahmen der Diagnostik und Therapie von Leberläsionen lassen sich noch weitere sinnvolle Indikationen in die tägliche Routine integrieren. Hierzu gehören z. B. intraoperative und vaskuläre Anwendungen sowie Einsatzmöglichkeiten bei anderen Organsystemen.
Abstract
Clinical/methodical issue
Contrast-enhanced ultrasound (CEUS) is becoming increasingly important for the detection and characterization of malignant liver lesions and allows percutaneous treatment when surgery is not possible. Contrast-enhanced ultrasound image fusion with computed tomography (CT) and magnetic resonance imaging (MRI) opens up further options for the targeted investigation of a modified tumor treatment.
Methodical innovations
Ultrasound image fusion offers the potential for real-time imaging and can be combined with other cross-sectional imaging techniques as well as CEUS.
Performance
With the implementation of ultrasound contrast agents and image fusion, ultrasound has been improved in the detection and characterization of liver lesions in comparison to other cross-sectional imaging techniques. In addition, this method can also be used for intervention procedures. The success rate of fusion-guided biopsies or CEUS-guided tumor ablation lies between 80 and 100% in the literature.
Achievements
Ultrasound-guided image fusion using CT or MRI data, in combination with CEUS, can facilitate diagnosis and therapy follow-up after liver interventions.
Practical recommendations
In addition to the primary applications of image fusion in the diagnosis and treatment of liver lesions, further useful indications can be integrated into daily work. These include, for example, intraoperative and vascular applications as well applications in other organ systems.
Literatur
Battaglia V, Cervelli R (2017) Liver investigations: updating on US technique and contrast-enhanced ultrasound (CEUS). Eur J Radiol 96:65–73
Bernatik T, Seitz K, Blank W et al (2010) Unclear focal liver lesions in contrast-enhanced ultrasonography – lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors. Ultraschall Med 31:577–581
Beyer LP, Wassermann F, Pregler B et al (2017) Characterization of focal liver lesions using CEUS and MRI with liver-specific contrast media: experience of a single radiologic center. Ultraschall Med 38:619–625
Bo XW, Xu HX, Guo LH et al (2017) Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers. Br J Radiol 90:20170063
Bruenn K, Beyer L, Haimerl M et al (2017) Comparison of computed tomography (CT) and contrast-enhanced ultrasound (CEUS) for the quantitative evaluation of an ablation defect following radiofrequency ablation of malignant liver lesions. Clin Hemorheol Microcirc 67:445–451
Clevert DA, Jung EM (2013) Interventional sonography of the liver and kidneys. Radiologe 53:962–973
Clevert DA, Helck A, Paprottka PM et al (2011) Latest developments in ultrasound of the liver. Radiologe 51:661–670
Clevert DA, Paprottka PM, Helck A et al (2012) Image fusion in the management of thermal tumor ablation of the liver. Clin Hemorheol Microcirc 52:205–216
Clevert DA, D’anastasi M, Jung EM (2013) Contrast-enhanced ultrasound and microcirculation: efficiency through dynamics – current developments. Clin Hemorheol Microcirc 53:171–186
Da Silva NPB, Beyer LP, Hottenrott MC et al (2017) Efficiency of contrast enhanced ultrasound for immediate assessment of ablation status after intraoperative radiofrequency ablation of hepatic malignancies. Clin Hemorheol Microcirc 66:357–368
Dong Y, Wang WP, Mao F et al (2016) Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound. J Gastroenterol Hepatol 31:822–828
Haimerl M, Brunn K, Poelsterl S et al (2017) Quantitative evaluation of real-time maximum liver capacity (LiMAx) and time intensity curve (TIC) analysis in CEUS-based microperfusion. Clin Hemorheol Microcirc 67:373–382
Jung EM, Clevert DA (2015) Possibilities of sonographic image fusion: current developments. Radiologe 55:937–948
Jung EM, Stroszczynski C (2016) Modern ultrasound diagnostic procedures in an interdisciplinary ultrasound department: challenge and opportunities for radiologists. Rofo 188:27–32
Jung EM, Uller W, Stroszczynski C et al (2011) Contrast-enhanced sonography. Therapy control of radiofrequency ablation and transarterial chemoembolization of hepatocellular carcinoma. Radiologe 51:462–468
Jung EM, Friedrich C, Hoffstetter P et al (2012) Volume navigation with contrast enhanced ultrasound and image fusion for percutaneous interventions: first results. PLoS ONE 7:e33956
Jung EM, Wiggermann P, Stroszczynski C et al (2012) Ultrasound diagnostics of diffuse liver diseases. Radiologe 52:706–716
Kang TW, Lee MW, Song KD et al (2017) Added value of contrast-enhanced ultrasound on biopsies of focal hepatic lesions invisible on fusion imaging guidance. Korean J Radiol 18:152–161
Li K, Su Z, Xu E et al (2017) Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients. BMC Cancer 17:61
Makino Y, Imai Y, Igura T et al (2016) Feasibility of extracted-overlay fusion imaging for Intraoperative treatment evaluation of radiofrequency ablation for hepatocellular carcinoma. Liver Cancer 5:269–279
Mauri G, Cova L, De Beni S et al (2015) Real-time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases. Cardiovasc Intervent Radiol 38:143–151
Min JH, Lim HK, Lim S et al (2014) Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B‑mode US: value of fusion imaging with contrast-enhanced US. Clin Mol Hepatol 20:61–70
Minami T, Minami Y, Chishina H et al (2014) Combination guidance of contrast-enhanced US and fusion imaging in radiofrequency ablation for hepatocellular carcinoma with poor conspicuity on contrast-enhanced US/fusion imaging. Oncology 87(Suppl 1):55–62
Mohr A, Jung EM, Stroszczynski C et al (2014) New economic training model for installing ultrasound-guided drainages. Z Gastroenterol 52:1257–1262
Muller-Peltzer K, Rubenthaler J, Reiser M et al (2017) Contrast-enhanced ultrasound (CEUS) of the liver : critical evaluation of use in clinical routine diagnostics. Radiologe 57:348–355
Niessen C, Beyer LP, Pregler B et al (2016) Percutaneous ablation of hepatic tumors using irreversible electroporation: a prospective safety and midterm efficacy study in 34 patients. J Vasc Interv Radiol 27:480–486
Partovi S, Lu Z, Kessner R et al (2017) Contrast enhanced ultrasound guided biopsies of liver lesions not visualized on standard B‑mode ultrasound-preliminary experience. J Gastrointest Oncol 8:1056–1064
Platz Batista Da Silva N, Schauer M, Hornung M et al (2016) Intrasurgical dignity assessment of hepatic tumors using semi-quantitative strain elastography and contrast-enhanced ultrasound for optimisation of liver tumor surgery. Clin Hemorheol Microcirc 64:735–745
Pregler B, Beyer LP, Wiesinger I et al (2016) Microwave ablation of large HCC lesions: added value of CEUS examinations for ablation success control. Clin Hemorheol Microcirc 64:483–490
Pregler B, Beyer LP, Wiesinger I et al (2017) Reduced microperfusion due to portal vein thrombosis: impact on the outcome of percutaneous thermal tumor ablation. Clin Hemorheol Microcirc 67:383–388
Pschierer K, Grothues D, Rennert J et al (2015) Evaluation of the diagnostic accuracy of CEUS in children with benign and malignant liver lesions and portal vein anomalies. Clin Hemorheol Microcirc 61:333–345
Rennert J, Georgieva M, Schreyer AG et al (2011) Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors. Clin Hemorheol Microcirc 49:67–81
Seitz K, Bernatik T, Strobel D et al (2010) Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI – a prospective comparison in 269 patients. Ultraschall Med 31:492–499
Sidhu PS, Cantisani V, Deganello A et al (2017) Authors’ reply to letter: role of contrast-enhanced ultrasound (CEUS) in paediatric practice: an EFSUMB position statement. Ultraschall Med 38:447–448
Sparchez Z, Mocan T, Radu P et al (2016) Contrast enhanced ultrasonography in assessing the treatment response to transarterial chemoembolization in patients with hepatocellular carcinoma. Med Ultrason 18:96–102
Sporea I, Badea R, Popescu A et al (2014) Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions – a prospective multicenter study of its usefulness in clinical practice. Ultraschall Med 35:259–266
Strobel D, Bernatik T, Blank W et al (2011) Diagnostic accuracy of CEUS in the differential diagnosis of small (〈/= 20 mm) and subcentimetric (〈/= 10 mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial. Ultraschall Med 32:593–597
Toma P (2017) Letter on the article: role of contrast-enhanced ultrasound (CE/US) in paediatric practice: an EFSUMB position statement. Ultraschall Med 38:446
Wein W, Khamene A, Clevert DA et al (2007) Simulation and fully automatic multimodal registration of medical ultrasound. Med Image Comput Comput Assist Interv 10:136–143
Wiesinger I, Wiggermann P, Zausig N et al (2017) Percutaneous treatment of malignant liver lesions: evaluation of success using contrast-enhanced ultrasound (CEUS) and perfusion software. Ultraschall Med. https://doi.org/10.1055/s-0043-119353
Wildner D, Pfeifer L, Goertz RS et al (2014) Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma. Ultraschall Med 35:522–527
Xu EJ, Lv SM, Li K et al (2017) Immediate evaluation and guidance of liver cancer thermal ablation by three-dimensional ultrasound/contrast-enhanced ultrasound fusion imaging. Int J Hyperthermia:1–7. https://doi.org/10.1080/02656736.2017.1373306
Yuan CH, Xiu DR, Ge HY et al (2013) Ultrasound guided ablation therapy of hepatic colorectal metastases: initial experience of real time virtual sonography navigation system. Beijing Da Xue Xue Bao Yi Xue Ban 45:956–959
Zhong-Zhen S, Kai L, Rong-Qin Z et al (2012) A feasibility study for determining ablative margin with 3D-CEUS-CT/MR image fusion after radiofrequency ablation of hepatocellular carcinoma. Ultraschall Med 33:E250–255
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
E.M. Jung und D.A. Clevert geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Jung, E.M., Clevert, D.A. Kontrastmittelsonographie (CEUS) und Bildfusion zur Durchführung von Leberinterventionen. Radiologe 58, 538–544 (2018). https://doi.org/10.1007/s00117-018-0411-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00117-018-0411-7
Schlüsselwörter
- Bildfusion
- Echtzeit-Bildgebung
- Kontrastmittelverstärkter Ultraschall
- Hepatozelluläres Karzinom
- Tumorvaskularisation